Pamela Reilly Contag
Chief Executive Officer at Cygnet, Inc.
Pamela Reilly Contag active positions
Companies | Position | Start | End |
---|---|---|---|
Cygnet, Inc.
Cygnet, Inc. Miscellaneous Commercial ServicesCommercial Services Cygnet, Inc. provides training, support, staffing, and operational strategy consulting services to the pharmaceutical and healthcare sectors. The private company is based in Somerset, NJ. The CEO of the company is Pamela Reilly Contag. | Chief Executive Officer | - | - |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Director/Board Member | - | - |
Chief Executive Officer | 2016-07-31 | - | |
Founder | - | - | |
President | - | - |
Career history of Pamela Reilly Contag
Former positions of Pamela Reilly Contag
Companies | Position | Start | End |
---|---|---|---|
MARRONE BIO INNOVATIONS, INC. | Director/Board Member | 2013-10-17 | 2016-05-24 |
Independent Dir/Board Member | 2013-10-17 | 2016-05-24 | |
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Founder | 1994-12-31 | 2005-12-31 |
President | 1994-12-31 | 2005-12-31 | |
ConcentRx Corp. | Chief Executive Officer | 2010-04-04 | - |
Chairman | 2010-04-04 | - | |
Founder | 2010-04-04 | - | |
Cobalt Technologies, Inc.
Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Chief Tech/Sci/R&D Officer | 2009-07-22 | 2012-04-12 |
Founder | 2009-07-22 | - | |
DELCATH SYSTEMS, INC. | Director/Board Member | 2008-12-10 | - |
Stanford University | Corporate Officer/Principal | - | - |
Training of Pamela Reilly Contag
St. Catherine University (Minnesota) | Undergraduate Degree |
University of Minnesota Medical School | Doctorate Degree |
Statistics
International
United States | 11 |
Operational
Founder | 4 |
Director/Board Member | 3 |
Chief Executive Officer | 3 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Process Industries | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DELCATH SYSTEMS, INC. | Health Technology |
Private companies | 6 |
---|---|
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
Cobalt Technologies, Inc.
Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Cobalt Technologies, Inc. develops, produces and commercializes bio-based chemicals. The firm engages in the creation of biobutanol using various cellulosic feedstocks, which include corn cobs, treetops and limbs and dead pine trees from pine beetles. It extracts fermentable sugars from biomass and converts them directly into bio n-butanol, which is an ingredient in coatings, paints, adhesives, sealants, inks and other solvent products. The company was founded by Pamela Reilly Contag in 2005 and is headquartered in Mountain View, CA. | Process Industries |
Pro Farm Group, Inc.
Pro Farm Group, Inc. Chemicals: AgriculturalProcess Industries Pro Farm Group, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. Its products include Grandevo Insecticide, Majestene Nematicide, Regalia Fungicide, Stargus Fungicide, Venerate Insecticide, Amplitude Fungicide, Regalia Rx Plant Health, Zelto Nematicide, Zequanox Molluscicide and Haven. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Raleigh, NC. | Process Industries |
ConcentRx Corp. | |
Cygnet, Inc.
Cygnet, Inc. Miscellaneous Commercial ServicesCommercial Services Cygnet, Inc. provides training, support, staffing, and operational strategy consulting services to the pharmaceutical and healthcare sectors. The private company is based in Somerset, NJ. The CEO of the company is Pamela Reilly Contag. | Commercial Services |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Pamela Reilly Contag
- Experience